En Es
Categories

CERTEST BIOTEC

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid tests. It offers a wide range of products for real time PCR that allow identification of causal pathogens causing infectious diseases and are suitable for use in physicians’ offices, laboratories and hospital ...
Products Covid-19Summary
Close

Covid-19 CERTEST BIOTEC

Clinical Laboratory

SARS-CoV-2 One Step Card Test
CerTest SARS-CoV-2

The CerTest SARS-CoV-2 one step card test is a coloured chromatographic immunoassay for the qualitative detection of SARS-CoV-2 from nasopharyngeal swab samples from patients with sign and symptoms of COVID-19 infection. It offers a simple and a highly sensitive screening assay as an aid in the diagnosis of SARS-CoV-2 infection.
More details

SARS-CoV-2/Influenza A+B/RSV Combo One Step Card Test
CerTest SARS-CoV-2 + Flu A + Flu B + RSV

The CerTest SARS-CoV-2 + Flu A + Flu B + RSV one step combo card test is a coloured chromatographic immunoassay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B and Respiratory Syncytial Virus from nasopharyngeal swab samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) infection. It offers a simple and highly sensitive screening assay as aid in the diagnosis of SARS-CoV-2 and/or Influenza type A and/or Influenza type B and/or RSV infection.
More details

SARS-CoV-2 Positive Control Kit
VIASURE Viral SARS-CoV-2 Positive Control Kit

The VIASURE Viral SARS-CoV-2 Positive Control Kit is intended for monitoring the whole reverse transcription quantitative real-time PCR (RT-qPCR) process, from nucleic acid extraction to reverse transcription and amplification steps. The kit contains non-replicative and non-infectious SARS-CoV-2 viral particles that are expected to be processed along with respiratory samples from individuals with clinical suspicion of COVID-19. It is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in molecular techniques and in vitro diagnostic procedures.
More details

SARS-CoV-2 & UK Variant RT-PCR Test
SARS-CoV-2 & UK Variant (S UK, ORF1ab and N genes)

The SARS-CoV-2 & UK Variant (S UK, ORF1ab and N genes) Real Time PCR Detection Kit is a real-time RT-PCR test designed for the qualitative detection of RNA from the SARS-CoV-2 and the HV 69/70 deletion of the S gene for SARS-CoV-2 associated to the SARS-CoV-2 VOC202012/01 (lineage B.1.1.7) variant and other variants in nasopharyngeal swabs from individuals suspected of COVID-19 infection by their healthcare professional (HCP). This test is intended for use as an aid in the diagnosis of SARS-CoV-2 as well as variants that carry the HV 69/70 deletion in combination with clinical and epidemiological risk factors.
More details

PCR Detection Kit
VIASURE MERS Coronavirus RT-PCR

The VIASURE MERS Coronavirus RT-PCR kit is designed for specific identification of MERS-CoV in clinical samples. The detection is done in a one-step real-time format where the reverse transcription and the subsequent amplification of specific target sequence occur in the same reaction well.
More details

PCR Detection Kit
VIASURE MERS Coronavirus

The VIASURE MERS Coronavirus real time PCR detection kit is designed for specific identification of MERS Coronavirus (MERS-CoV) in clinical samples from patients with signs and symptoms of MERS Coronavirus infection. The detection is done in a one-step real time RT format where the reverse transcription and the subsequent amplification of specific target sequence occur in the same reaction well.
More details
Close

About CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid tests. It offers a wide range of products for real time PCR that allow identification of causal pathogens causing infectious diseases and are suitable for use in physicians’ offices, laboratories and hospitals.

Recently updated

SARS-CoV-2 & UK Variant RT-PCR Test
SARS-CoV-2 & UK Variant (S UK, ORF1ab and N genes)

The SARS-CoV-2 & UK Variant (S UK, ORF1ab and N genes) Real Time PCR Detection Kit is a real-time RT-PCR test designed for the qualitative detection of RNA from the SARS-CoV-2 and the HV 69/70 deletion of the S gene for SARS-CoV-2 associated to the SARS-CoV-2 VOC202012/01 (lineage B.1.1.7) variant and other variants in nasopharyngeal swabs from individuals suspected of COVID-19 infection by their healthcare professional (HCP). This test is intended for use as an aid in the diagnosis of SARS-CoV-2 as well as variants that carry the HV 69/70 deletion in combination with clinical and epidemiological risk factors.
More details

SARS-CoV-2 Positive Control Kit
VIASURE Viral SARS-CoV-2 Positive Control Kit

The VIASURE Viral SARS-CoV-2 Positive Control Kit is intended for monitoring the whole reverse transcription quantitative real-time PCR (RT-qPCR) process, from nucleic acid extraction to reverse transcription and amplification steps. The kit contains non-replicative and non-infectious SARS-CoV-2 viral particles that are expected to be processed along with respiratory samples from individuals with clinical suspicion of COVID-19. It is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in molecular techniques and in vitro diagnostic procedures.
More details

SARS-CoV-2/Influenza A+B/RSV Combo One Step Card Test
CerTest SARS-CoV-2 + Flu A + Flu B + RSV

The CerTest SARS-CoV-2 + Flu A + Flu B + RSV one step combo card test is a coloured chromatographic immunoassay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B and Respiratory Syncytial Virus from nasopharyngeal swab samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) infection. It offers a simple and highly sensitive screening assay as aid in the diagnosis of SARS-CoV-2 and/or Influenza type A and/or Influenza type B and/or RSV infection.
More details

Clinical Laboratory

SARS-CoV-2 & UK Variant RT-PCR Test
SARS-CoV-2 & UK Variant (S UK, ORF1ab and N genes)

The SARS-CoV-2 & UK Variant (S UK, ORF1ab and N genes) Real Time PCR Detection Kit is a real-time RT-PCR test designed for the qualitative detection of RNA from the SARS-CoV-2 and the HV 69/70 deletion of the S gene for SARS-CoV-2 associated to the SARS-CoV-2 VOC202012/01 (lineage B.1.1.7) variant and other variants in nasopharyngeal swabs from individuals suspected of COVID-19 infection by their healthcare professional (HCP). This test is intended for use as an aid in the diagnosis of SARS-CoV-2 as well as variants that carry the HV 69/70 deletion in combination with clinical and epidemiological risk factors.
More details

SARS-CoV-2 Positive Control Kit
VIASURE Viral SARS-CoV-2 Positive Control Kit

The VIASURE Viral SARS-CoV-2 Positive Control Kit is intended for monitoring the whole reverse transcription quantitative real-time PCR (RT-qPCR) process, from nucleic acid extraction to reverse transcription and amplification steps. The kit contains non-replicative and non-infectious SARS-CoV-2 viral particles that are expected to be processed along with respiratory samples from individuals with clinical suspicion of COVID-19. It is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in molecular techniques and in vitro diagnostic procedures.
More details

SARS-CoV-2/Influenza A+B/RSV Combo One Step Card Test
CerTest SARS-CoV-2 + Flu A + Flu B + RSV

The CerTest SARS-CoV-2 + Flu A + Flu B + RSV one step combo card test is a coloured chromatographic immunoassay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B and Respiratory Syncytial Virus from nasopharyngeal swab samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) infection. It offers a simple and highly sensitive screening assay as aid in the diagnosis of SARS-CoV-2 and/or Influenza type A and/or Influenza type B and/or RSV infection.
More details

SARS-CoV-2 One Step Card Test
CerTest SARS-CoV-2

The CerTest SARS-CoV-2 one step card test is a coloured chromatographic immunoassay for the qualitative detection of SARS-CoV-2 from nasopharyngeal swab samples from patients with sign and symptoms of COVID-19 infection. It offers a simple and a highly sensitive screening assay as an aid in the diagnosis of SARS-CoV-2 infection.
More details

Respiratory Test Kit
VIASURE Respiratory Panel IV

The VIASURE Respiratory Panel IV Real Time PCR Detection Kit is intended for use as an aid in the diagnosis of Flu A and/or B; Influenza A H1N1)2009; RSV A and/or B; Parainfluenzas viruses; AdV, MPV and/or BoV, HRV and/or HEV; CoV 229E, NL63, OC43 and/or HKU1 strains in combination with clinical and epidemiological risk factors. The RNA/DNA is extracted from clinical specimens, multiplied using Real Time amplification and detected using specific primers and a fluorescent reporter dye probe.
More details

Streptococcal Test
CerTest Strep A

The CerTest Strep A one step card test is a colored chromatographic immunoassay for the qualitative detection of Group A Streptococcal from throat swabs and suspected Group A Streptococcal colonies recovered from culture. It offers a simple and highly sensitive screening assay to make a presumptive diagnosis of Group A Streptococcal respiratory infection.
More details

Adenovirus Test
CerTest Adenovirus Resp.

The CerTest Adenovirus Resp. one step card test is a colored chromatographic immunoassay for the qualitative detection of Adenovirus from nasal swab, nasopharyngeal wash or aspirate specimens. It offers a simple and a highly sensitive screening assay to make a presumptive diagnosis of Adenovirus respiratory infection.
More details

Immunoassay Test
CerTest Legionella

The CerTest Legionella is a colored chromatographic immunoassay for the qualitative detection of Legionella pneumophila serogroup 1 in human urine samples. It offers a highly sensitive and simple screening assay to make a presumptive diagnosis of legionelosis in infected humans with a time to result of 15 minutes.
More details

Quantitative Aassay
CerTest FOB Turbilatex

The CerTest FOB Turbilatex is a quantitative assay that offers a simple, a highly sensitive and non-invasive screening assay to make a presumptive diagnosis of gastrointestinal bleeding. It detects intact or nearly intact human hemoglobin, being a very specific technique for detecting loss of blood from the lower intestine.
More details

Rapid Test
VIASURE Gastrointestinal Panel I

The VIASURE Gastrointestinal Panel I is designed for the specific identification and differentiation of Salmonella, Campylobacter and/or Yersinia enterocolitica; Shigella/EIEC; Cryptosporidium, Giardia lamblia and/or Entamoeba histolytica; Norovirus GI and/or Norovirus GII (NoV); Rotavirus (RV); Adenovirus (AdV); Astrovirus (AstV); and/or Sapovirus (SaV) in human stool samples from patients with signs and symptoms of gastrointestinal infection. It is intended for use as an aid in the diagnosis of Salmonella, Campylobacter and/or Y. enterocolitica; Shigella/EIEC; Cryptosporidium, G. lamblia and/or E. histolytica; NoV GI and/or NoV GII; RV; AdV; AstV; and/or SaV infection in combination with clinical and epidemiological risk factors.
More details

Combo Immunoassay Test
Influenza A + Influenza B + RSV + Adenovirus Resp.

The Influenza A + Influenza B + RSV + Adenovirus Resp. one step combo card test is a colored chromatographic immunoassay for the simultaneous qualitative detection of Influenza type A and type B, Respiratory Syncytial Virus and Adenovirus antigens from nasopharyngeal swab, nasopharyngeal wash or aspirate specimens. It is a simple and a highly sensitive screening assay to make a presumptive diagnosis of Influenza type A and B, Respiratory Syncytial Virus and/or Adenovirus respiratory infection.
More details

Real PCR Detection Kit
VIASURE Flu Typing I

The VIASURE Flu Typing I Real PCR Detection Kit is designed for the specific identification and differentiation of Influenza A (H1N1)pdm09 and H3N2 subtypes in respiratory samples from patients with signs and symptoms of respiratory infection. The RNA is extracted from specimens, amplified using RT-PCR and detected using fluorescent reporter dye probes specific for Influenza A (H1N1)pdm09 and H3N2 subtypes.
More details

PCR Detection Kit
VIASURE MERS Coronavirus RT-PCR

The VIASURE MERS Coronavirus RT-PCR kit is designed for specific identification of MERS-CoV in clinical samples. The detection is done in a one-step real-time format where the reverse transcription and the subsequent amplification of specific target sequence occur in the same reaction well.
More details

PCR Detection Kit
VIASURE MERS Coronavirus

The VIASURE MERS Coronavirus real time PCR detection kit is designed for specific identification of MERS Coronavirus (MERS-CoV) in clinical samples from patients with signs and symptoms of MERS Coronavirus infection. The detection is done in a one-step real time RT format where the reverse transcription and the subsequent amplification of specific target sequence occur in the same reaction well.
More details

Immunoassay Test
CerTest S. pneumoniae + Legionella

The CerTest S. pneumoniae + Legionella one-step combo card test is a colored chromatographic immunoassay for the simultaneous qualitative detection of Streptococcus pneumoniae and Legionella pneumophila serogroup 1 in human urine samples. The rapid test delivers results in 15 minutes using a urine specimen, which is convenient for collection, transport, and subsequent detection of early, as well as later, stages of disease.
More details

PCR Detection Kit
VIASURE

The VIASURE kit is designed for specific detection and differentiation of Zika, Dengue and/or Chikungunya viruses in samples from patients with signs/symptoms of infection. The test is intended for use as an aid in diagnosis, in combination with clinical and epidemiological risk factors.
More details
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions